[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"imaging-three-dimensional--methods\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:imaging-three-dimensional--methods":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,47],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":31,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100539629","3d-facial-scanning-for-evaluating-autologous-fat-grafting-in-craniofacial-deformities-100539629",false,"NCT06306326","3D Facial Scanning for Evaluating Autologous Fat Grafting in Craniofacial Deformities","Application of Three-dimensional Facial Scanning Images in Evaluating the Therapeutic Efficacy of Autologous Fat Grafting in the Treatment of Craniofacial Deformities","Inclusion Criteria:\n\n* Facial soft tissue volume deficiency deformity caused by congenital\u002Facquired factors, meeting the indications for autologous fat grafting surgery.\n* Good physical health, without severe systemic diseases or infectious diseases.\n* Not pregnant and without plans for pregnancy.\n* Signed informed consent form.\n\nExclusion Criteria:\n\n* Contraindications to general anesthesia.\n* Patient refusal to participate in this study.\n* Significant contour changes in non-filled facial areas during follow-up period leading to inability to register data.",true,"ALL","3 Years","80 Years",{"count":21,"type":22},100,"ESTIMATED","INTERVENTIONAL",[25],"NA","Treatment of craniofacial deformities is a significant topic in oral and maxillofacial surgery, and autologous fat grafting has become one of the main methods for treating facial concave deformities. However, the instability of its treatment effect has always been a bottleneck in this field, mainly due to the uncertain absorption rate of transplanted fat. This project aims to use advanced the 3dMD face system (3dMD) (3dMD Inc, Atlanta, Ga) technology to precisely measure the facial volume changes before and after autologous fat grafting to address this issue. By performing autologous fat grafting surgery on 100 patients with craniofacial deformities that meet the research criteria, 3dMD technology will be used for facial three-dimensional scanning preoperatively, immediately postoperatively, and at six months postoperatively to obtain facial volume data. Then, through precise data analysis, we will calculate the fat absorption rate and study the effects of individual factors on treatment outcomes through correlation regression analysis.",[28,29,30],"Adipocytes","Autografts","Imaging, Three-Dimensional \u002F Methods",[32,33],"Autologous Fat Grafting","3dMD","RECRUITING","2026-06-05",{"date":37,"type":38},"2026-06-09","ACTUAL",{"date":40,"type":38},"2024-04-27",{"date":42,"type":22},"2029-04-15",{"name":44,"class":45},"Peking University","OTHER",1,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":4,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":17,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":4,"studyType":23,"phases":58,"briefSummary":59,"conditions":60,"keywords":64,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":46},"100571189","a-study-of-3d-visualization-techniques-to-improve-the-quality-and-safety-of-robot-assisted-nephron-sparing-surgery-for-complex-renal-tumors-100571189","NCT06717009","A Study of 3D Visualization Techniques to Improve the Quality and Safety of Robot-assisted Nephron Sparing Surgery for Complex Renal Tumors.","A Prospective, Multicenter, Randomized Controlled Study of Three-dimensional Visualization Techniques to Improve the Quality and Safety of Robot-assisted Nephron Sparing Surgery for Complex Renal Tumors","Inclusion Criteria:\n\n1. The imaging diagnosis is single renal cell carcinoma, clinical stage is T1N0M0-T2N0M0, and the contralateral kidney function is good.\n2. Physical status and organ function allow robotic-assisted partial nephrectomy.\n3. Be able to adhere to the protocol during the study.\n4. The age ranges from 18 to 75 years, and there is no chronic kidney disease.\n5. KPS \\> 80; ECOG score: 0-1; There are no other serious concomitant diseases and the organ function is good.\n6. There are no medical contraindications seriously affecting anesthesia and surgery.\n7. The patient has no history of other malignant tumors in the past 5 years.\n8. There is no surgical history of epigastrium and the affected kidney.\n9. Estimated survival is more than 6 months, and there are no other severe diseases that reduce survival to less than 5 years.\n\nExclusion Criteria:\n\n1. Women who are pregnant or lactating, or who are of reproductive age and are not using effective contraception.\n2. Comorbid serious medical diseases or conditions, for example, clinically severe or active heart disease, severe uncontrolled medical illnesses and infections, severe uncontrolled digestive disorder, severe electrolyte disturbance, active disseminated intravascular coagulation, major organ failure such as decompensated cardiac, pulmonary, hepatic, or renal failure, symptomatic peripheral neuropathy. Can not tolerate robot-assisted laparoscopic partial nephrectomy\n3. Organ transplant recipients requiring immunosuppressive therapy.\n4. There is history of other malignancies within 5 years of trial initiation, excluding cured basal cell carcinoma of the skin and carcinoma in situ of the cervix.\n5. Patients who have received biological therapy or other anticancer traditional Chinese medicine within 4 weeks.\n6. Patients with multiple or bilateral renal tumors or solitary renal tumors.\n7. Patient without complete clinical information.","18 Years","75 Years",{"count":57,"type":22},350,[25],"The goal of this clinical trial is to learn the evidence-based medical value of 3D visualization techniques to improve tumor control, preservation of renal function, and perioperative safety in robot-assisted nephron sparing surgery for complex renal tumors. The main question it aims to answer is:\n\nIs 3D visualization techniques more effective in improving robot-assisted nephron sparing surgery for complex renal tumors in terms of tumor control, renal function preservation, and perioperative safety.\n\nThe researchers will randomize participants into a 3D trial group and a conventional group for comparison.\n\nParticipants will:\n\nComplete Blood routine, liver and kidney function tests on the first and third day after operation.\n\nHave Renography at 3 and 12 months after the operation. Cooperate with follow-up visits.",[61,62,30,63],"Kidney Neoplasms \u002F Surgery","Robotic Surgical Procedures","Nephrectomy \u002F Methods",[65,66,67,68,69,70],"Three-dimensional visualization technique;","Three-dimensional reconstruction","Robotic surgery","Kidney neoplasms","Laparoscopy","Nephron sparing surgery","NOT_YET_RECRUITING","2024-11-29",{"date":74,"type":38},"2024-12-04",{"date":76,"type":22},"2025-01",{"date":78,"type":22},"2027-10",{"name":80,"class":45},"Tianjin Medical University Cancer Institute and Hospital"]